Dose- and schedule-dependent protective efficacy of celgosivir in a lethal mouse model for dengue virus infection informs dosing regimen for a proof of concept clinical trial.
(Q40278537)
scientific article published on 31 July 2012
scientific article published on 31 July 2012
Language: